Popular weight-loss drugs may play surprising role in cancer outcomes
GLP-1 drugs like Ozempic and Wegovy may lower cancer risk by altering the body's immune response, but researchers say key clinical trials are needed.
GLP-1 drugs like Ozempic and Wegovy may lower cancer risk by altering the body's immune response, but researchers say key clinical trials are needed.
Read the full article on Fox News
Read Full Article →